Why the study?
In-stent restenosis is closely associated with abnormal endothelial shear stress distribution, making stent design optimization crucial to mitigate neointimal hyperplasia and thrombosis.
Does multidimensional stent design optimization improve endothelial shear stress distribution and mitigate thrombosis and restenosis?
Does multidimensional stent design optimization improve endothelial shear stress distribution and mitigate thrombosis and restenosis?
Multidimensional optimization of stent design, particularly through thinner struts and streamlined geometries, is critical for maintaining physiological endothelial shear stress and preventing stent-related complications like restenosis and thrombosis.
Stent design optimization may reduce ISR via ESS modulation; leaves open which parameters warrant prospective clinical validation.
The occurrence of in-stent restenosis (ISR) is closely associated with abnormal distribution of endothelial shear stress (ESS), and optimizing stent design is crucial for improving patient prognosis. This review aims to comprehensively explore how stent design parameters-including geometric structure and surface functionalization-influence neointimal hyperplasia and thrombosis by modulating ESS, while also summarizing the latest technological strategies. A detailed discussion is provided on the design evolution from traditional coronary stents to for non-coronary arteries (cerebral aneurysm) micro-woven stents, analyzing the mechanisms by which factors such as streamlined profiles, reduced strut thickness, and optimized spacing improve hemodynamics. Furthermore, the article critically evaluates the advantages and current limitations of cutting-edge technologies such as computational fluid dynamics (CFD)-based optimization and endothelialization-promoting functional coatings. We conclude that multidimensional stent design optimization represents a future trend in regulating ESS and suppressing restenosis. Future research should focus on integrating personalized design with highly biocompatible materials to advance the clinical translation of next-generation vascular stents.
No takes yet. Share an insight, caveat, or question.
Che et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: